NanoViricides Files Quarterly Report for Period Ending March 31, 2019 - HerpeCide(TM) Drug Candidate Pre-IND Application Submitted, Progressing Towards Clinical Trials
Stock Information for NanoViricides Inc.
Loading
Please wait while we load your information from QuoteMedia.